Pharmaceutical Technology6 天
Trientine hydrochloride by Innolife for Amyloidosis: Likelihood of Approval
Trientine hydrochloride is under clinical development by Innolife and currently in Phase I for Amyloidosis. According to GlobalData, Phase I drugs for Amyloidosis have a 91% phase transition success ...
Pharmaceutical Technology6 天
Pimicotinib hydrochloride by Abbisko Therapeutics for Pancreatic Cancer: Likelihood of Approval
Pimicotinib hydrochloride is under clinical development by Abbisko Therapeutics and currently in Phase I for Pancreatic Cancer.